|
Apr 18
|
Lexicon Pharmaceuticals to Host 2024 Investor Day
|
|
Apr 16
|
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
|
|
Apr 3
|
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 25
|
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
|
|
Mar 13
|
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin
|
|
Mar 12
|
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
|
|
Mar 11
|
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 11
|
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
|
|
Mar 11
|
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
|
|
Mar 11
|
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
|
|
Jan 23
|
3 of the Fastest-Growing Stocks on the Planet in 2024
|
|
Jan 11
|
Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) largest shareholders are private equity firms with 48% ownership, institutions own 24%
|
|
Jan 8
|
Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 21
|
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference
|
|
Nov 30
|
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
|
|
Oct 11
|
Lexicon's (LXRX) Inpefa Gets Preferred Status at Express Scripts
|
|
Oct 11
|
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
|
|
Oct 10
|
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
|
|
Oct 10
|
Midday movers: PepsiCo, Unity, Rivian Automotive and more
|
|
Oct 10
|
Lexicon Pharma shares rise after Inpefa gets preferred status at Express Scripts
|